NORTHERN TRUST CORP - CONTRAVIR PHARMACEUTICALS IN ownership

CONTRAVIR PHARMACEUTICALS IN's ticker is CTRV and the CUSIP is 21234W202. A total of 20 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of CONTRAVIR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2019$4,000
-33.3%
19,9350.0%0.00%
Q4 2018$6,000
-45.5%
19,9350.0%0.00%
Q3 2018$11,000
-57.7%
19,9350.0%0.00%
Q2 2018$26,00019,9350.00%
Other shareholders
CONTRAVIR PHARMACEUTICALS IN shareholders Q1 2019
NameSharesValueWeighting ↓
Prospera Financial Services Inc 16,323$4,0000.00%
VANGUARD GROUP INC 101,131$23,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 3,280$1,0000.00%
BARCLAYS PLC 84,034$19,0000.00%
BANK OF AMERICA CORP /DE/ 336$00.00%
WELLS FARGO & COMPANY/MN 305$00.00%
NORTHERN TRUST CORP 19,935$4,0000.00%
Capital Advisors, Ltd. LLC 22$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 3,112$1,0000.00%
View complete list of CONTRAVIR PHARMACEUTICALS IN shareholders